Drug–Device Combination Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2222 | Report Format : | Status : Upcoming |


Drug–Device Combination Products Market: Overview

According to the U.S. Food and Drug Administration (FDA) and, a mixture product is distinct as, “Two or more part products packaged jointly in a sole package or as a unit and consist of drug and tool products, device and natural products, or biological and treatment products”. The increasing occurrence of chronic diseases amongst old population makes an inevitable requirement for efficient beneficial solutions. In light of such requirement, pharmaceutical and therapeutic tool industries now introducing drug–device combination products. Rising number of aged population, rising health care expenses along with the growing demand for point-of-care checkups are few of the fundamental features that encourage the development of the global drug-device combination market. Furthermore, dynamic interventions starting the NGO and government associations, along with the rising popularity for simple insidious surgeries, would finally drive the market development in the coming years. On the other hand, the high price of drugs, growing incidences of chronic illness, negative side effects linked with products and rising technological challenges to distributing drugs would act as a most important limitation for the market.

Drug–Device Combination Products Market: Growth Factors

The drug-device combination market is mainly motivated by exponential development in the manufacturing of highly developed drug deliverance plans coupled with the rising chronic illness burden, which is projected to be one of the most important features to hasten on the whole demand of the product in the market in the coming years. The exceptional acceptance rate of these products is also assumed to be a result of its inbuilt benefits over the conventional pharmacological options to bring therapeutics, which in turn persuades biotechnology, pharmaceutical and medicinal device companies to work further rising these products for successive commercialization.

Drug–Device Combination Products Market: Segmentation

The global drug–device combination products market is divided into application, product types, and geography. On the basis of product types, the market is classified as Inhalers, photosensitizers, wound care products, orthopedic products, infusion pumps, transdermal patches, drug eluting stents, and others. On the other hand, the application section is categorized as ophthalmic treatment, bone treatment, cardiovascular, non-cardiovascular, antimicrobial treatment, urological, cancer treatment, and diabetes treatment.

Drug–Device Combination Products Market: Regional Analysis

Geographically, the global market for drug–device combination products market has been divided into Rest of the World, Asia Pacific, Europe, and North America. Amongst these regions, in terms of returns, the drug–device combination market is dominated by North America. On the other hand, Asia Pacific is anticipated to see high development owing to the rising occurrence of cardiovascular diseases, diabetes, and obesity, building the most lucrative market in the future.

Drug–Device Combination Products Market: Competitive Players

The key players in the drug–device combination products market are W. L. Gore & Associates, Inc., Ethicon, Inc., Stryker Corporation, C.R. Bard, Inc., Pinnacle Biologics, Inc., CareFusion Corporation, Medline Industries, Inc., Covidien PLC, Mylan, Inc., Terumo Corporation, and Medtronic, Inc.

Global Drug–Device Combination Products Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Drug Designing Tools Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3432 | Report Format:

Global Drug Designing Tools Market: Overview Drug designing tools refer to computer modeling proficiencies that offer insights into findings of experimental nature. These tools utilize computational chemistry for discovering, enhancing, and studying varied drugs and their related active biologic...Read More

Medical Marijuana Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3424 | Report Format:

Global Medical Marijuana Market: Overview Marijuana is a greenish-gray mixture of the cannabis sativas dried flowers. Medical marijuana is still in the inception stage in the medical industry. The chemical properties of medical marijuana can be used to treat various symptoms and diseases, such a...Read More

Legal Marijuana Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3423 | Report Format:

Global Legal Marijuana Market: Overview Cannabis is basically a flowering plant. This plant has several varieties; hemp and marijuana are two of these varieties. Owing to the fact that cannabinoids (THC) is very psychoactive in nature and causes intoxication, cannabis or marijuana is not legaliz...Read More

Cannabis Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3422 | Report Format:

Global Cannabis Testing Market: Overview Cannabis is basically a psychoactive drug primarily used for recreational and medical purposes. The expansion of the global cannabis testing market can be attributed to the increasing recognition of cannabis for therapeutic and medical uses by the medical...Read More

Erectile Dysfunction Drugs Market by Drug (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), by Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3395 | Report Format:

The report covers forecast and analysis for the erectile dysfunction drugs market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the erectile ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.